The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Operational metrics for the ELAINE II study combining a traditional approach with a just-in-time model.
 
Sibel Blau
Employment - Northwest Medical Specialties
Leadership - Northwest Medical Specialties; Quality Cancer Care Alliance
Stock and Other Ownership Interests - All4cure (I); Northwest Medical Specialties
Honoraria - American Journal of Managed Care; Cardinal Health; Novartis; Puma Biotechnology
Research Funding - Northwest Medical Specialties
Expert Testimony - Northwest Medical Specialties
Travel, Accommodations, Expenses - Northwest Medical Specialties; Quality Cancer Care Alliance
Other Relationship - All4Cure (I); Northwest Medical Specialties; Quality Cancer Care Alliance
 
Julio Antonio Peguero
Employment - Oncology Consultants
Leadership - Oncology Consultants
Stock and Other Ownership Interests - Oncology Consultants; Roche; Spectrum Pharmaceuticals; Tersera; zogen
Honoraria - Agendia; Guardant Health; Tempus
Consulting or Advisory Role - Tersera
Speakers' Bureau - Agendia; Guardant Health; Tempus
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); BerGenBio (Inst); Boehringer Ingelheim (Inst); Calithera Biosciences (Inst); Dizal Pharma (Inst); eFFECTOR Therapeutics (Inst); EMD Serono (Inst); Epizyme (Inst); Genentech/Roche (Inst); Immatics (Inst); ImmunityBio (Inst); Immutep (Inst); IncMed (Inst); Incyte (Inst); Ipsen (Inst); Janssen (Inst); Kechow Pharma (Inst); Lilly (Inst); Loxo/Lilly (Inst); Macrogenics (Inst); Mirati Therapeutics (Inst); Natera (Inst); Novartis (Inst); NovoCure (Inst); Sermonix Pharmaceuticals (Inst); Tersera (Inst); Thrive Earlier Detection Corp (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Agendia; Guardant Health; Tempus
 
Halle C. F. Moore
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Roche (Inst); Sermonix Pharmaceuticals (Inst)
 
Ian Churchill Anderson
Research Funding - Abbvie (Inst); Apollomics (Inst); AstraZeneca (Inst); EMD Serono (Inst); Hutchison MediPharma (Inst); Merck (Inst); Seagen (Inst); Turning Point Therapeutics (Inst)
 
Minal A. Barve
Employment - Texas Oncology
Stock and Other Ownership Interests - Texas Oncology
Research Funding - Mary Crowley Research Center, Dallas Texas
 
Mathew Amprayil Cherian
No Relationships to Disclose
 
Ahmed Elkhanany
No Relationships to Disclose
 
Ciara Catherine Maria O'Sullivan
Honoraria - Seagen (Inst)
Research Funding - Bavarian Nordic (Inst); Biovica (Inst); Lilly (Inst); Minneamrita Therapeutics (Inst); Seagen (Inst)
 
Alvaro Moreno-Aspitia
Stock and Other Ownership Interests - Merrimack
Research Funding - Abbvie (Inst); Daiichi Sankyo (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from the development of a xenograft model. Royalties were assigned to go to my institution and not personally
 
Paul Plourde
Employment - Sermonix Pharmaceuticals
Leadership - Sermonix Pharmaceuticals
Stock and Other Ownership Interests - Sermonix Pharmaceuticals
 
Lyon L. Gleich
Employment - Medpace
Stock and Other Ownership Interests - Medpace
 
Kendra Riesen
Employment - Medpace
 
Ross Ezzati
Employment - Medpace
Stock and Other Ownership Interests - Medpace
 
Meghan Degele
Employment - Tempus
 
Megan Shulman
Employment - Tempus
 
Stephanie Stempf
Employment - CATO SMS; Tempus
Stock and Other Ownership Interests - Tempus
Patents, Royalties, Other Intellectual Property - Trade secret filings and copyright. Artificial intelligence revenue cycle (I)
 
Matthew M. Cooney
Employment - Parexel International; Tempus
 
Senthil Damodaran
Research Funding - EMD Serono (Inst); Guardant Health (Inst); Novartis (Inst); Sermonix Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst)